AI In Clinical Trials: Why Process Orchestration Matters More Than The Model

By Abraham Gutman, Founder & CEO, AG Mednet

AI is rapidly becoming a larger part of clinical trial operations, powering tasks such as data review, eligibility screening, anomaly detection, and document summarization. But AI alone does not accelerate trials. Its value depends on how effectively outputs are routed, reviewed, acted upon, and documented within regulated workflows. Here we explore the critical infrastructure required to move from data generation to decision execution. the article argues that successful AI adoption is not about replacing human expertise, but about embedding AI into governed, auditable processes where responsibilities, handoffs, and accountability are clearly defined. As AI takes on more operational work, human experts remain responsible for the decisions that shape trial outcomes.

Discover why the future of clinical research depends not just on smarter AI, but on the workflow architecture that connects data, technology, and human judgment.